The estimated Net Worth of Dennis Chookaszian is at least $15.9 Milione dollars as of 14 March 2023. Mr. Chookaszian owns over 16,000 units of CME Inc stock worth over $15,640,552 and over the last 20 years he sold CME stock worth over $0. In addition, he makes $258,432 as Independent Director at CME Inc.
Sign up
Mr. Chookaszian CME stock SEC Form 4 insiders trading
Dennis has made over 4 trades of the CME Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 16,000 units of CME stock worth $45,120 on 14 March 2023.
The largest trade he's ever made was buying 40,000 units of CME Inc stock on 12 March 2013 worth over $501,200. On average, Dennis trades about 1,414 units every 63 days since 2004. As of 14 March 2023 he still owns at least 71,552 units of CME Inc stock.
You can see the complete history of Mr. Chookaszian stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dennis Chookaszian biography
Dennis H. Chookaszian serves as Independent Director of the Company. Mr. Chookaszian served as Chairman of the Financial Accounting Standards Advisory Council from 2007 to 2011. From 1999 until 2001, Mr. Chookaszian served as Chairman and CEO of mPower, Inc., a financial advice provider focused on the online management of 401(k) plans. Mr. Chookaszian served as Chairman and CEO of CNA Insurance Companies from 1992 to 1999. During his 27-year career with CNA, Mr. Chookaszian held several management positions at the business unit and corporate levels, including President and COO from 1990 to 1992 and CFO from 1975 to 1990. Mr. Chookaszian is a registered certified public accountant.
What is the salary of Dennis Chookaszian?
As the Independent Director of CME Inc, the total compensation of Dennis Chookaszian at CME Inc is $258,432. There are 14 executives at CME Inc getting paid more, with Terrence Duffy having the highest compensation of $11,867,200.
How old is Dennis Chookaszian?
Dennis Chookaszian is 76, he's been the Independent Director of CME Inc since 2004. There are 1 older and 41 younger executives at CME Inc. The oldest executive at CME Group Inc is Dennis Suskind, 77, who is the Independent Director.
Insiders trading at CME Inc
Over the last 21 years, insiders at CME Inc have traded over $264,111,034 worth of CME Inc stock and bought 77,667 units worth $15,169,350 . The most active insiders traders include Terrence A Duffy, Phupinder Gill e Bryan T Durkin. On average, CME Inc executives and independent directors trade stock every 10 days with the average trade being worth of $863,868. The most recent stock trade was executed by Bryan T Durkin on 30 August 2024, trading 7,593 units of CME stock currently worth $1,629,382.
What does CME Inc do?
as the world's leading and most diverse derivatives marketplace, cme group (www.cmegroup.com) is where the world comes to manage risk. cme group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. cme group brings buyers and sellers together through its cme globex® electronic trading platform and its trading facilities in new york and chicago. cme group also operates cme clearing, one of the world’s leading central counterparty clearing provider in the world, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through cme clearport®. these products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.
What does CME Inc's logo look like?
Complete history of Mr. Chookaszian stock trades at Veradigm Inc, CME Inc, Loop Industries Inc e Perdoceo Education
CME Inc executives and stock owners
CME Inc executives and other stock owners filed with the SEC include:
-
Terrence Duffy,
Executive Chairman of the Board, Chief Executive Officer -
Michael Spencer,
Director -
Terrence A. Duffy,
Chairman & CEO -
John Pietrowhicz,
Chief Financial Officer -
Sean Tully,
Senior Managing Director - Financial and OTC Products -
Julie Holzrichter,
Chief Operating Officer, Senior Managing Director -
Kevin Kometer,
Chief Information Officer, Senior Managing Director -
John William Pietrowicz M.B.A., CPA,
Chief Financial Officer -
Kevin D. Kometer,
Sr. MD & Chief Information Officer -
Julie Holzrichter,
Sr. MD & COO -
Sunil Cutinho,
Pres of CME Clearing -
Dennis Suskind,
Independent Director -
Daniel Glickman,
Lead Independent Director -
Larry Gerdes,
Independent Director -
Dennis Chookaszian,
Independent Director -
Timothy Bitsberger,
Independent Director -
Howard Siegel,
Independent Director -
Martin Gepsman,
Independent Director -
William Shepard,
Independent Director -
Elizabeth Cook,
Independent Director -
Terry Savage,
Independent Director -
Charles Carey,
Vice Chairman of the Board -
Ronald Pankau,
Independent Director -
Deborah Lucas,
Independent Director -
William Hobert,
Independent Director -
Ana Dutra,
Independent Director -
Gedon Hertshten,
Independent Director -
Daniel Kaye,
Independent Director -
Phyllis Lockett,
Independent Director -
Yra Harris,
Independent Director -
Patrick Maloney,
Independent Director -
Julie Winkler,
Senior Managing Director, Chief Commercial Officer -
Kendal Vroman,
Senior Managing Director - International and Optimization Services -
Derek Sammann,
Senior Managing Director - Commodity and Options -
Kathleen Cronin,
Senior Managing Director, General Counsel, Corporate Secretary -
Jack Tobin,
Chief Accounting Officer -
Hilda Piell,
Chief Human Resource Officer, Senior Managing Director -
Sunil Cutinho,
President - CME Clearing -
Hilda Harris Piell,
Sr. MD & Chief HR Officer -
Anita Liskey,
Sr. Managing Director of Corp. Marketing & Communications -
Kathleen M. Cronin,
Sr. MD, Gen. Counsel & Corp. Sec. -
John C. Peschier,
Managing Director of Investor Relations -
Jack Tobin,
MD & Chief Accounting Officer -
Kimberly S Taylor,
MD & Pres., Clearing House -
John W. Pietrowicz,
Sr MD Chief Financial Officer -
Robert Zagotta,
Director -
Phupinder Gill,
Managing Director, Clearing -
Jeffrey M. Bernacchi,
Director -
Leo Melamed,
Director -
John F Sandner,
Director -
Alex J Pollock,
Director -
David J Wescott,
Director -
James E. Parisi,
MD & CFO -
Steven E Wollack,
Director -
William P Ii Miller,
Director -
James E Oliff,
Director -
Jill A Harley,
MD & CAO -
J. Dennis Hastert,
Director -
Bruce F Johnson,
Director -
James A Donaldson,
Director -
C C Ii Odom,
Director -
Linda Dallas Rich,
Sr MD Govt Rel Legisl Affairs -
Laurent Paulhac,
MD OTC Products -
James V. Pieper,
MD & CAO -
Christopher Stewart,
Director -
Jackie M Clegg,
Director -
Scot E. Warren,
MD Equity Index Prod & Svcs -
Gary M Katler,
Director -
Mark E Cermak,
Director -
Joseph Niciforo,
Director -
Mazen Chadid,
MD Operations -
James R Krause,
Man. Director, Operations -
Eileen Keeve,
Managing Director -
Myron S Scholes,
Director -
Richard H Redding,
MD, Products & Services -
Barry C Goldblatt,
MD Comm Energy & Metal Prods -
Patrick B Lynch,
Director -
Nancy W Goble,
Man. Dir & Chief Acc. Off -
Elizabeth Harrington,
Director -
John Roth Iii Roberts,
MD & CMO -
Scott Gordon,
Director -
Robert J Jr Tierney,
Director -
Robert H Steele,
Director -
Satish Nandapurkar,
Managing Director -
Scott L Johnston,
Man. Dir. & Chief Inf. Off. -
Craig S Donohue,
EVP & CAO, Office of the CEO -
William G Jr Salatich,
Director -
Robert F Corvino,
Director -
John P Iii Davidson,
MD & Chief Corp Dev Officer -
David G Gomach,
Managing Director & CFO -
John L Pietrzak,
Director -
James J Mcnulty,
President & CEO -
James E Newsome,
Director -
Scott Robinson,
MD, Corporate Development -
Bryan T Durkin,
Director -
Michael G. Dennis,
Director -
Patrick J Mulchrone,
Director -
Rahael Seifu,
Director -
Suzanne Sprague,
Sr MD Global Head of Clearing -
Timothy Francis Mc Court,
Sr MD Global Head Equity & FX -
Ken Vroman,
Chief Transformation Officer -
Jonathan L Marcus,
Sr MD General Counsel -
Kathryn Benesh,
Director -
Harold Eugene Jr. Ford,
Director -
Lynne Fitzpatrick,
Sr MD Chief Financial Officer